What’s New

News Nov 18, 2024
Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial

September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality…

Interview Jul 19, 2024
Expanding the Alimentiv Site Network: An Interview With Peter Westerveld

The Alimentiv Site Network (ASN) is our worldwide network of gastrointestinal (GI) centers that collaborate with us. With an established global reputation for high-quality monitoring…

Publication Sep 8, 2017
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis
Publication Aug 26, 2017
Alicaforsen for the treatment of inflammatory bowel disease
Publication Aug 3, 2017
Evolving Concepts in Phases I and II Drug Development for Crohn’s Disease
Publication Jul 29, 2017
Reliability of EUS indices to detect inflammation in ulcerative colitis
Publication Jul 21, 2017
Histologic scoring indices for evaluation of disease activity in Crohn’s disease
Publication Jun 27, 2017
The development of a magnetic resonance imaging index for fistulising Crohn’s disease